Apolipoprotein E, amyloid-ß clearance and therapeutic opportunities in Alzheimer's disease
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Apolipoprotein E, amyloid-ß clearance and therapeutic opportunities in Alzheimer's disease
Authors
Keywords
-
Journal
Alzheimers Research & Therapy
Volume 4, Issue 4, Pages 32
Publisher
Springer Nature
Online
2012-12-06
DOI
10.1186/alzrt135
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reducing Human Apolipoprotein E Levels Attenuates Age-Dependent A Accumulation in Mutant Human Amyloid Precursor Protein Transgenic Mice
- (2012) N. Bien-Ly et al. JOURNAL OF NEUROSCIENCE
- The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
- (2012) Iryna Benilova et al. NATURE NEUROSCIENCE
- APOE-Mimetic Peptides Reduce Behavioral Deficits, Plaques and Tangles in Alzheimers Disease Transgenics
- (2012) M.P. Vitek et al. Neurodegenerative Diseases
- Genetic variation at CR1 increases risk of cerebral amyloid angiopathy
- (2012) A. Biffi et al. NEUROLOGY
- ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models
- (2012) P. E. Cramer et al. SCIENCE
- Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer's disease
- (2012) Sascha Weggen et al. Alzheimers Research & Therapy
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Animal models in the drug discovery pipeline for Alzheimer's disease
- (2011) Debby Van Dam et al. BRITISH JOURNAL OF PHARMACOLOGY
- Rosiglitazone Does Not Improve Cognition or Global Function when Used as Adjunctive Therapy to AChE Inhibitors in Mild-to-Moderate Alzheimers Disease: Two Phase 3 Studies
- (2011) C. Harrington et al. Current Alzheimer Research
- High ability of apolipoprotein E4 to stabilize amyloid-β peptide oligomers, the pathological entities responsible for Alzheimer's disease
- (2011) Emilie Cerf et al. FASEB JOURNAL
- Small Molecule Structure Correctors Abolish Detrimental Effects of Apolipoprotein E4 in Cultured Neurons
- (2011) Hung-Kai Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Apolipoprotein E Promotes β-Amyloid Trafficking and Degradation by Modulating Microglial Cholesterol Levels
- (2011) C. Y. Daniel Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Haploinsufficiency of Human APOE Reduces Amyloid Deposition in a Mouse Model of Amyloid- Amyloidosis
- (2011) J. Kim et al. JOURNAL OF NEUROSCIENCE
- APOE modifies the association between A load and cognition in cognitively normal older adults
- (2011) K. Kantarci et al. NEUROLOGY
- Apolipoprotein E: Isoform Specific Differences in Tertiary Structure and Interaction with Amyloid-β in Human Alzheimer Brain
- (2011) Phillip B. Jones et al. PLoS One
- Lack of LDL Receptor Enhances Amyloid Deposition and Decreases Glial Response in an Alzheimer's Disease Mouse Model
- (2011) Loukia Katsouri et al. PLoS One
- Functional Links Between A Toxicity, Endocytic Trafficking, and Alzheimer's Disease Risk Factors in Yeast
- (2011) S. Treusch et al. SCIENCE
- Human apoE Isoforms Differentially Regulate Brain Amyloid- Peptide Clearance
- (2011) J. M. Castellano et al. Science Translational Medicine
- APP processing in Alzheimer's disease
- (2011) Yun-wu Zhang et al. Molecular Brain
- Alzheimer's disease genetics: current knowledge and future challenges
- (2010) Paul Hollingworth et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer’s amyloid β-peptide elimination from the brain
- (2010) Berislav V. Zlokovic et al. JOURNAL OF NEUROCHEMISTRY
- Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe
- (2010) H. H. Feldman et al. NEUROLOGY
- Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review
- (2009) Hannah AD Keage et al. BMC Neurology
- Clearance of Amyloid-β Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimers Disease
- (2009) R. Deane et al. CNS & Neurological Disorders-Drug Targets
- Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease
- (2009) A. Drzezga et al. NEUROLOGY
- A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
- (2009) S. Salloway et al. NEUROLOGY
- Overexpression of Low-Density Lipoprotein Receptor in the Brain Markedly Inhibits Amyloid Deposition and Increases Extracellular Aβ Clearance
- (2009) Jungsu Kim et al. NEURON
- A new amyloid β variant favoring oligomerization in Alzheimer's-type dementia
- (2008) Takami Tomiyama et al. ANNALS OF NEUROLOGY
- Apolipoprotein E ɛ4 magnifies lifestyle risks for dementia: a population-based study
- (2008) Miia Kivipelto et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- apoE isoform–specific disruption of amyloid β peptide clearance from mouse brain
- (2008) Rashid Deane et al. JOURNAL OF CLINICAL INVESTIGATION
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started